[Form 4] Amphenol Corporation Insider Trading Activity

Rhea-AI Filing Summary

Peter Straub, an officer (President, ISS Division) of Amphenol Corporation (APH), reported option exercises and simultaneous open-market sales on 09/08/2025. He exercised two stock option grants: one with a $22.37 exercise price (44,000 shares exercisable 05/23/2020, expiring 05/23/2029) and one with a $22.55 exercise price (44,000 shares exercisable 05/21/2021, expiring 05/21/2030). On the same date he sold 88,000 Class A shares in multiple trades at a weighted average sale price of $110.6357 (individual trades ranged $110.55–$111.035). After these transactions he held 176,000 Class A shares directly related to outstanding options and reported 0 Class A shares owned following the sales for the exercised tranches.

Positive

• Full disclosure of exercise prices, exercisable and expiration dates and sale price range improves transparency
• Weighted-average sale price and note on trade range ($110.55–$111.035) provide detailed execution information

Negative

• Large insider sales of 88,000 shares on 09/08/2025 may be viewed negatively by some investors seeking insider accumulation
• Post-sale reported ownership shows 0 shares for the exercised tranches, reducing this officer's direct holdings from those specific grants

Insights

Securities Analyst

TL;DR: Officer exercised options at ~ $22 and sold the resulting shares at ~ $110.64, realizing substantial spread without changing delegated ownership structure.

The filing shows routine option exercises followed by immediate sales on the same date. The exercises reflect the conversion of vested options (strike prices $22.37 and $22.55) into shares and disposition in multiple trades at a weighted average of $110.6357. The disclosure includes execution-range detail and a power-of-attorney signature. For investors this is a non-operational insider liquidity event rather than a corporate action affecting Amphenol's capital structure.

Corporate Governance Expert

TL;DR: Transparent Form 4 shows option exercise and market sales; disclosures include price range and POA signature, consistent with compliance norms.

The report identifies the reporting person and relationship to the issuer and provides required details: grant exercise dates, exercisable/expiration dates, option quantities, and sale price range. The inclusion of weighted average price and note about multiple trades improves clarity. There is no indication of 10% ownership or change to board composition. The filing appears procedurally complete and compliant with Section 16 reporting requirements.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Straub Peter

(Last) (First) (Middle)

C/O AMPHENOL CORPORATION

358 HALL AVENUE

(Street)

WALLINGFORD CT 06492

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AMPHENOL CORP /DE/ [ APH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, ISS Division

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/08/2025		M		44,000	A	$22.37	44,000	D
Class A Common Stock	09/08/2025		S		44,000	D	$110.6357(1)(2)	0	D
Class A Common Stock	09/08/2025		M		44,000	A	$22.55	44,000	D
Class A Common Stock	09/08/2025		S		44,000	D	$110.6357(1)(2)	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$22.37	09/08/2025		M			44,000	05/23/2020	05/23/2029	Class A Common Stock	44,000	$0	0	D
Stock Option	$22.55	09/08/2025		M			44,000	05/21/2021	05/21/2030	Class A Common Stock	44,000	$0	176,000	D

Explanation of Responses:

1. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

2. This transaction was executed in multiple trades ranging from $110.55 to $111.035.

	/s/ Lance E. D'Amico, POA	09/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did APH insider Peter Straub do on 09/08/2025?

He exercised two stock options (44,000 shares each) and sold a total of 88,000 Class A shares in multiple trades at a weighted average price of $110.6357.

What were the exercise prices and option details?

Exercise prices were $22.37 (options exercisable 05/23/2020, expiring 05/23/2029) and $22.55 (exercisable 05/21/2021, expiring 05/21/2030), 44,000 options each.

How many shares did the reporting person own after these transactions?

Following the reported sales, the filing shows 0 Class A shares held from the exercised tranches and a reported 176,000 Class A shares related to outstanding options in Table II prior to reduction.

What price range were the sales executed at?

Sales executed in multiple trades ranging from $110.55 to $111.035, with a weighted average sale price reported as $110.6357.

Who signed the Form 4 filing?

The form was signed by Lance E. D'Amico, POA on behalf of the reporting person on 09/09/2025.